EdgarLookup

Cannae Holdings, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Cannae Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-102.7%
Profit Margin
Net income ÷ revenue
-38.9%
Return on Assets
Net income ÷ assets
0.32x
Debt-to-Equity
Total liabilities ÷ equity
+3.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $499.70M Feb 29, 2024
FY2023 Dec 31, 2022 $483.40M Feb 29, 2024
FY2023 Dec 31, 2021 $452.50M Feb 29, 2024
FY2022 Dec 31, 2020 $2.97B Mar 1, 2023
FY2021 Dec 31, 2019 $1.44B Feb 25, 2022
FY2020 Dec 31, 2018 $1.32B Feb 26, 2021
FY2019 Dec 31, 2017 $1.17B Mar 2, 2020
FY2018 Dec 31, 2016 $1.19B Mar 18, 2019
FY2017 Dec 31, 2015 $1.43B Mar 26, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $423.60M Mar 2, 2026
FY2025 Dec 31, 2024 $452.50M Mar 2, 2026
FY2025 Dec 31, 2023 $570.00M Mar 2, 2026
FY2024 Dec 31, 2022 $662.10M Feb 27, 2025
FY2023 Dec 31, 2021 $742.20M Feb 29, 2024
FY2022 Dec 31, 2020 $585.70M Mar 1, 2023
FY2021 Dec 31, 2019 $1.07B Feb 25, 2022
FY2020 Dec 31, 2018 $1.15B Feb 26, 2021
FY2019 Dec 31, 2017 $1.16B Mar 2, 2020
FY2018 Dec 31, 2016 $1.18B Mar 18, 2019

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $1.17B Mar 26, 2018
FY2017 Dec 31, 2016 $1.18B Mar 26, 2018
FY2017 Dec 31, 2015 $1.41B Mar 26, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($513.20M) Mar 2, 2026
FY2025 Dec 31, 2024 ($304.60M) Mar 2, 2026
FY2025 Dec 31, 2023 ($313.40M) Mar 2, 2026
FY2024 Dec 31, 2022 ($428.10M) Feb 27, 2025
FY2023 Dec 31, 2021 ($287.00M) Feb 29, 2024
FY2022 Dec 31, 2020 $1.79B Mar 1, 2023
FY2021 Dec 31, 2019 $77.30M Feb 25, 2022
FY2020 Dec 31, 2018 $27.60M Feb 26, 2021
FY2019 Dec 31, 2017 $108.80M Mar 2, 2020
FY2018 Dec 31, 2016 ($12.40M) Mar 18, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($119.60M) Mar 2, 2026
FY2025 Dec 31, 2024 ($103.70M) Mar 2, 2026
FY2025 Dec 31, 2023 ($118.90M) Mar 2, 2026
FY2024 Dec 31, 2022 ($144.60M) Feb 27, 2025
FY2023 Dec 31, 2021 ($133.50M) Feb 29, 2024
FY2022 Dec 31, 2020 ($188.50M) Mar 1, 2023
FY2021 Dec 31, 2019 ($117.60M) Feb 25, 2022
FY2020 Dec 31, 2018 ($145.80M) Feb 26, 2021
FY2019 Dec 31, 2017 ($77.50M) Mar 2, 2020
FY2018 Dec 31, 2016 ($2.20M) Mar 18, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($18.10M) Mar 2, 2026
FY2025 Dec 31, 2024 ($90.10M) Mar 2, 2026
FY2025 Dec 31, 2023 ($87.80M) Mar 2, 2026
FY2024 Dec 31, 2022 ($205.10M) Feb 27, 2025
FY2023 Dec 31, 2021 ($176.10M) Feb 29, 2024
FY2022 Dec 31, 2020 ($113.90M) Mar 1, 2023
FY2021 Dec 31, 2019 ($84.20M) Feb 25, 2022
FY2020 Dec 31, 2018 ($22.90M) Feb 26, 2021
FY2019 Dec 31, 2017 ($90.70M) Mar 2, 2020
FY2018 Dec 31, 2016 $60.30M Mar 18, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $15.60M Mar 18, 2019
FY2018 Dec 31, 2017 $39.00M Mar 18, 2019
FY2018 Dec 31, 2016 $49.60M Mar 18, 2019
FY2017 Dec 31, 2015 $55.40M Mar 26, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.32B Mar 2, 2026
FY2025 Dec 31, 2024 $2.23B Mar 2, 2026
FY2025 Dec 31, 2023 $2.69B Mar 2, 2026
FY2024 Dec 31, 2022 $3.13B Feb 27, 2025
FY2023 Dec 31, 2021 $3.89B Feb 29, 2024
FY2022 Dec 31, 2020 $4.61B Mar 1, 2023
FY2021 Dec 31, 2019 $2.09B Feb 25, 2022
FY2020 Dec 31, 2018 $1.46B Feb 26, 2021
FY2019 Dec 31, 2017 $1.49B Mar 2, 2020
FY2018 Dec 31, 2016 $1.47B Mar 18, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $329.80M Mar 2, 2026
FY2025 Dec 31, 2024 $413.60M Mar 2, 2026
FY2024 Dec 31, 2023 $377.50M Feb 27, 2025
FY2023 Dec 31, 2022 $410.60M Feb 29, 2024
FY2022 Dec 31, 2021 $548.50M Mar 1, 2023
FY2021 Dec 31, 2020 $828.20M Feb 25, 2022
FY2020 Dec 31, 2019 $562.40M Feb 26, 2021
FY2019 Dec 31, 2018 $259.80M Mar 2, 2020
FY2018 Dec 31, 2017 $334.10M Mar 18, 2019
FY2017 Dec 31, 2016 $463.50M Mar 26, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.02B Mar 2, 2026
FY2025 Dec 31, 2024 $1.84B Mar 2, 2026
FY2024 Dec 31, 2023 $2.32B Feb 27, 2025
FY2023 Dec 31, 2022 $2.72B Feb 29, 2024
FY2022 Dec 31, 2021 $3.34B Mar 1, 2023
FY2021 Dec 31, 2020 $3.78B Feb 25, 2022
FY2020 Dec 31, 2019 $1.49B Feb 26, 2021
FY2019 Dec 31, 2018 $1.12B Mar 2, 2020
FY2018 Dec 31, 2017 $1.06B Mar 18, 2019
FY2017 Dec 31, 2016 $893.50M Mar 26, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $53.40M Mar 2, 2026
FY2025 Dec 31, 2024 $53.40M Mar 2, 2026
FY2025 Dec 31, 2023 $53.40M Mar 2, 2026
FY2024 Dec 31, 2022 $53.40M Feb 27, 2025
FY2023 Dec 31, 2021 $53.40M Feb 29, 2024
FY2022 Dec 31, 2020 $53.40M Mar 1, 2023
FY2021 Dec 31, 2019 $66.10M Feb 25, 2022
FY2020 Dec 31, 2018 $76.50M Feb 26, 2021
FY2019 Dec 31, 2017 $103.20M Mar 2, 2020
FY2018 Dec 31, 2016 $103.10M Mar 18, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $23.30M Mar 2, 2026
FY2025 Dec 31, 2024 $567.10M Mar 2, 2026
FY2024 Dec 31, 2023 $901.30M Feb 27, 2025
FY2023 Dec 31, 2022 $1.21B Feb 29, 2024
FY2022 Dec 31, 2021 $1.64B Mar 1, 2023
FY2021 Dec 31, 2020 $1.93B Feb 25, 2022
FY2020 Dec 31, 2019 $143.60M Feb 26, 2021
FY2019 Dec 31, 2018 $45.80M Mar 2, 2020
FY2018 Dec 31, 2017 $200.0K Mar 18, 2019
FY2017 Dec 31, 2016 $0 Mar 26, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $182.00M Mar 2, 2026
FY2025 Dec 31, 2024 $131.50M Mar 2, 2026
FY2024 Dec 31, 2023 $106.20M Feb 27, 2025
FY2023 Dec 31, 2022 $247.70M Feb 29, 2024
FY2022 Dec 31, 2021 $85.80M Mar 1, 2023
FY2021 Dec 31, 2020 $724.70M Feb 25, 2022
FY2020 Dec 31, 2019 $533.70M Feb 26, 2021
FY2019 Dec 31, 2018 $315.70M Mar 2, 2020
FY2018 Dec 31, 2017 $245.60M Mar 18, 2019
FY2017 Dec 31, 2016 $141.70M Mar 26, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $70.80M Mar 2, 2026
FY2025 Dec 31, 2024 $181.00M Mar 2, 2026
FY2024 Dec 31, 2023 $105.00M Feb 27, 2025
FY2023 Dec 31, 2022 $97.40M Feb 29, 2024
FY2022 Dec 31, 2021 $16.40M Mar 1, 2023
FY2021 Dec 31, 2020 $63.50M Feb 25, 2022
FY2020 Dec 31, 2019 $127.10M Feb 26, 2021
FY2019 Dec 31, 2018 $48.10M Mar 2, 2020
FY2018 Dec 31, 2017 $134.90M Mar 18, 2019
FY2017 Dec 31, 2016 $104.70M Mar 26, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (9) Mar 2, 2026
FY2025 Dec 31, 2024 (4) Mar 2, 2026
FY2025 Dec 31, 2023 (4) Mar 2, 2026
FY2024 Dec 31, 2022 (5) Feb 27, 2025
FY2023 Dec 31, 2021 (3) Feb 29, 2024
FY2022 Dec 31, 2020 20 Mar 1, 2023
FY2021 Dec 31, 2019 1 Feb 25, 2022
FY2020 Dec 31, 2018 0 Feb 26, 2021
FY2019 Dec 31, 2017 1 Mar 2, 2020
FY2018 Dec 31, 2016 0 Mar 18, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (9) Mar 2, 2026
FY2025 Dec 31, 2024 (4) Mar 2, 2026
FY2025 Dec 31, 2023 (4) Mar 2, 2026
FY2024 Dec 31, 2022 (5) Feb 27, 2025
FY2023 Dec 31, 2021 (3) Feb 29, 2024
FY2022 Dec 31, 2020 20 Mar 1, 2023
FY2021 Dec 31, 2019 1 Feb 25, 2022
FY2020 Dec 31, 2018 0 Feb 26, 2021
FY2019 Dec 31, 2017 1 Mar 2, 2020
FY2018 Dec 31, 2016 0 Mar 18, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 46.70M Mar 2, 2026
FY2025 Dec 31, 2024 62.79M Mar 2, 2026
FY2024 Dec 31, 2023 70.37M Feb 27, 2025
FY2023 Dec 31, 2022 76.25M Feb 29, 2024
FY2022 Dec 31, 2021 86.89M Mar 1, 2023
FY2021 Dec 31, 2020 91.65M Feb 25, 2022
FY2020 Dec 31, 2019 79.52M Feb 26, 2021
FY2019 Dec 31, 2018 72.22M Mar 2, 2020
FY2018 Dec 31, 2017 70.86M Mar 18, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $30.50M Mar 2, 2026
FY2025 Dec 31, 2024 $22.40M Mar 2, 2026
FY2025 Dec 31, 2023 $0 Mar 2, 2026
FY2024 Dec 31, 2022 $0 Feb 27, 2025